Streetbeat News

Products Services

CLOV

Clover Health Investments Corp (NASDAQ:CLOV) shares rose by 4.6% after the company announced an increase in its PPO Medicare Advantage plans' Star rating to 4 Stars for 2025, impacting payments in 2026. The HMO plan rating also improved to 3.5 Stars, with 95% of members covered by PPO plans. The improvement was driven by high scores in healthcare quality metrics, attributed to Clover Assistant technology.

Portfolio Pulse from Henry Khederian

October 11, 2024 | 4:40 pm

SOFI

SoFi Technologies, Inc. (NASDAQ:SOFI) shares are trading higher due to the launch of two new credit cards and positive economic data, including a Federal Reserve interest rate cut. The company is set to report its Q3 financial results on Oct. 29, with expected earnings of 4 cents per share and revenue of $629.217 million.

Portfolio Pulse from Erica Kollmann

October 11, 2024 | 4:32 pm

TSLA

Tesla's Robotaxi Day event was met with mixed reactions from analysts, with many expressing disappointment over the lack of clear business plans and updates on lower-cost production vehicles. Despite this, some analysts remain optimistic about Tesla's long-term prospects, particularly in AI and robotics. Tesla's stock has seen a decline following the event.

Portfolio Pulse from Chris Katje

October 11, 2024 | 4:26 pm

NCNA

A BioRxiv article discusses the potential of NUC-3373, a phosphoramidate modification of FUDR, to enhance immunogenicity in colorectal cancer cells, potentially improving the efficacy of immunotherapies. The study shows that NUC-3373 can cause DNA damage and release DAMPs, increasing lymphocyte-induced cell death.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 4:23 pm

CAPR

Capricor Therapeutics announced positive 3-year results from its HOPE-2 study for deramiocel, showing sustained cardiac and skeletal benefits in treating Duchenne muscular dystrophy. The study highlights improvements in cardiac function and a favorable safety profile, boosting CAPR stock by 8.05%.

Portfolio Pulse from Vandana Singh

October 11, 2024 | 4:18 pm

TVGN

Tevogen Bio is expanding its pipeline to include non-oncology products, aiming to maximize ROI from its ExacTcell technology. The company focuses on developing T cell therapeutics for both cancer and infectious diseases, with a strategy to enhance supportive care for cancer patients.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 4:14 pm

MSFT

Microsoft has unveiled new healthcare AI tools, including data solutions for Microsoft Fabric and application templates for Microsoft Purview, to enhance the analysis of biomedical data. These tools aim to improve data integration, storage, and analysis, and offer healthcare-specific AI models and agent services.

Portfolio Pulse from Vandana Singh

October 11, 2024 | 4:12 pm

BMY

CATX

Perspective Therapeutics' stock (NYSE: CATX) fell 13% following the release of initial results from a study on their radiopharmaceutical therapy, [212Pb]VMT01. The study showed some efficacy but also suggested the need for lower dosing. The Safety Monitoring Committee recommended exploring a lower dose level, both as a monotherapy and in combination with Bristol Myers Squibb's Opdivo (nivolumab).

Portfolio Pulse from Vandana Singh

October 11, 2024 | 4:05 pm

BITF

CAN

CLSK

HIVE

HUT

MARA

RIOT

Shares of miners and crypto-linked stocks are experiencing an uptick due to a rise in Bitcoin prices.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 4:01 pm

AMD

FCFY

HPE

KNGZ

Hewlett Packard Enterprise (HPE) shares rose after BofA Securities maintained a Buy rating with a $24 target. HPE unveiled a fanless liquid cooling system and a new AI-optimized server, highlighting its engineering strengths. The company is poised to benefit from increased data center adoption of liquid cooling.

Portfolio Pulse from Lekha Gupta

October 11, 2024 | 3:40 pm